This report presents a comprehensive overview of the Cell Based Assays market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.

This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Cell Based Assays industry.

This report focuses Global and Europe market, including details as following:

Key Players
Merck KGaA (Germany)
Becton (U.S.)
PerkinElmer Inc. (U.S.)
Promega Corporation (U.S.)
Danaher Corporation (U.S.)
GE Healthcare (U.K)
Thermo Fisher Scientific Inc. (U.S.)
Cell Signaling Technology, Inc. (U.S.)
BioTek Instruments, Inc. (U.S.)
Lonza Group (U.S.)
ProQinase GmbH (Germany)
Charles River Laboratories, Inc (U.S.)
Cisbio Bioassays (France)
Miltenyi Biotec (Germany)
Cell Biolabs, Inc. (U.S.)
DiscoverX Corporation (U.S.)
Marin Biologic Laboratories (U.S.)
Biospherix, Ltd (U.S.)
Essen BioScience Inc. (U.S.)
Cell Biologics Inc. (U.S.)
BioAgilytix Labs. (U.S.)
Enzo Life Sciences, Inc. (Switzerland)
Aurelia Bioscience Ltd. (U.K. )
Selexis SA (U.S.)
QGel SA (Switzerland)

Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Key Product Type
By product type: Consumables, Instruments, Services, Software.
By Usage Type: Drug discovery, Basic Research, ADME Studies, Predictive Toxicology, Other Applications.

Key Applications
Pharmaceutical & Biotechnology Companies
Academic & Government Institutions
Contract Research Organizations
Other End Users